A30G (p.Ala30Gly) variant of SPAST (Spastin)

A30G (p.Ala30Gly) in SPAST (Spastin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data and structural context.

A30G (p.Ala30Gly) variant details